candesartan has been researched along with Vascular Diseases in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan significantly reduced the development of coronary arteriosclerosis (intima/media ratio: 0." | 3.73 | The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy. ( Fukuda, D; Sata, M; Takamoto, S; Yamamoto, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tiefenbacher, CP | 1 |
| Friedrich, S | 1 |
| Bleeke, T | 1 |
| Vahl, C | 1 |
| Chen, X | 1 |
| Niroomand, F | 1 |
| Yamamoto, T | 1 |
| Sata, M | 1 |
| Fukuda, D | 1 |
| Takamoto, S | 1 |
2 other studies available for candesartan and Vascular Diseases
| Article | Year |
|---|---|
ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.
Topics: Acetylcholine; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibito | 2004 |
The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arteriosclerosis; Benzimidazoles; Biphenyl Compoun | 2006 |